Moneycontrol
HomeNewsBusinessEconomyEuropean Central Bank's stimulus train to keep on rolling
Trending Topics

European Central Bank's stimulus train to keep on rolling

The bank’s governing council made the decision Thursday to keep benchmark interest rates, the size of its bond-buying stimulus programs and its outlook unchanged.

September 10, 2020 / 18:58 IST
Story continues below Advertisement

The European Central Bank left its key stimulus policies unchanged on September 10, with almost a trillion euros (dollars) still in the pipeline to bolster the eurozone economy's rebound from the severe coronavirus recession.

Story continues below Advertisement

ECB President Christine Lagarde said the economy had shown “a strong rebound in activity” since the lockdowns eased but remained “well below” pre-virus levels.

She said high uncertainty about the path of the economy's recovery meant that “ample monetary stimulus remains necessary” and repeated intentions to keep the ECB's pandemic emergency bond purchase stimulus running through mid-2021.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show